BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024

  August 8, 2024

   · 

  4 min read
• Press Releases

  Genprex to Present at the August Sidoti Microcap Conference

  August 8, 2024

   · 

  5 min read
• 

  Earnings

  Lilly Beats Q2 Expectations as Tirzepatide Supply Stabilizes, Raises Full-Year Revenue Guidance by $3B

  Eli Lilly comfortably cleared analyst estimates in the second quarter after improving supply of its blockbuster tirzepatide brands Mounjaro and Zepbound, which together generated more than $4 billion in sales.

  August 8, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Virios Therapeutics Announces Second Quarter 2024 Financial Results

  August 8, 2024

   · 

  6 min read
• Press Releases

  GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

  August 8, 2024

   · 

  6 min read
• 

  Lung Cancer

  Merck Halts Phase III Trial of Keytruda, Anti-TIGIT Combo in Small Cell Lung Cancer

  The pharma said Thursday it is stopping a late-stage study of its blockbuster Keytruda plus the anti-TIGIT antibody vibostolimab and chemotherapy as a first-line treatment for extensive-stage small cell lung cancer, following a recommendation from an independent data monitoring committee.

  August 8, 2024

   · 

  2 min read

   · 

  Tyler Patchen
• 

  Press Releases

  Spatial OMICS Market to Soar USD 906.13 Million by 2033 at a 9.50% CAGR, says Healthcare Analyst

  August 8, 2024

   · 

  14 min read
• 

  Press Releases

  Stem Cell Therapy Market Set to Skyrocket to $48.89 Billion by 2033, Fueled by 13.2% CAGR

  August 8, 2024

   · 

  13 min read
• Business

  Medigene AG to Report Half-Year 2024 Financial Results on August 14, 2024

  August 8, 2024

   · 

  2 min read
• Press Releases

  Distinct Pattern in Protein Production Can Predict Severe Side Effects from Skin Cancer Treatment

  August 8, 2024

   · 

  5 min read